PPOAFVALVEtrial

Phase 2

Recruiting

• Conditions: D006349; Heart valve disease

• Registration Number: JPRN-jRCTs011190012
• Lead Sponsor: Shingu Yasushige

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-03-18
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 145

Inclusion Criteria

Patients who undergo heart valve surgery

Exclusion Criteria

Patients with atrial fibrillation ventricular arrhythmia, unstable angina, acute myocardial infarction, hemodialysis, digitalis, and class I and III antiarrhythmic agents; pregnant women; emergent case

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Postoperative atrial fibrillation for more than 30 seconds within 5 days after surgery

Secondary Outcome Measures

Name	Time	Method
Duration of postoperative hospitalization; complications; duration of atrial fibrillation; postoperative atrial flutter for more than 30 seconds within 5 days after surgery; duration of atrial flutter